Clinical trial Recruiting at 1 site Observational Ages 18 and up

i-STAT Alinity whole-blood test for adults with head injury in the emergency department

Official title: Effectiveness of the Traumatic Brain Injury Whole Blood Test on Improving Assessment and Triage for Patients With GCS 13-15 Presenting to Emergency Departments

Run by University of Pittsburgh · NCT07373509 · Data updated 2026-11-12

This project will try the i-STAT Alinity whole-blood test in adults with recent mild head injuries (GCS 13–15) to see if it helps decide who needs a head CT.

More TBI (Traumatic Brain Injury) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment340 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedJanuary 13, 2026
Main results expectedMarch 2029
Study endsApril 2030
Registry record updatedJuly 6, 2026
Trial IDNCT07373509 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who present to a participating ED within 24 hours of blunt head trauma, have a Glasgow Coma Scale of 13–15, and meet the DoD definition of mild TBI are the intended participants.

Probably not a fit

Patients with more severe injuries (GCS <13), those for whom the treating clinician already decides a CT is unnecessary, or cases where the i-STAT Alinity result cannot be obtained in a timely manner are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational implementation project uses the i-PARIHS framework to study use of the i-STAT Alinity whole-blood TBI test in emergency departments. About 140 adult patients with GCS 13–15 will be enrolled (roughly 47 per site) to compare test results with CT utilization and clinical outcomes. Key outcomes include the proportion of patients with non-elevated test results who still receive CT scans, differences in ED length of stay when the test is used, and the test's ability to predict return ED visits for the same injury. The study also measures implementation determinants such as acceptability, adoption, appropriateness, and feasibility at organizational and provider levels.

Why it matters

Potential benefit: If successful, using this blood test could reduce unnecessary head CTs, shorten ED stays, and help clinicians make faster, safer decisions after mild head injury.

How similar studies have gone: Preliminary data and prior biomarker research suggest similar test performance (about 21% of non-elevated tests paired with CT scans), but routine ED implementation of this whole-blood platform is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 18 or older
2. Presenting to an enrolling ED with ED Arrival GCS of 13-15 following reported head blunt impact within 24 hours of injury
3. Meets Department of Defense (DoD) definition of mTBI:

A traumatically induced physiological disruption of brain function as a result of an external force that is indicated by new onset or worsening of at least one of the following clinical signs immediately following the event:

1. Any alteration of mental status (e.g., feeling dazed, disoriented, or confused)
2. Any period of loss of or a decreased level of consciousness, observed or self-report (loss of consciousness 30 minutes or less, an alteration of consciousness up to 24 hours)
3. Any loss of memory for events immediately before or after the injury (post-traumatic amnesia up to 1-day post-injury)

Exclusion Criteria:

1. Treating emergency department provider does not think a head CT scan is needed
2. Inability to obtain results for iSTAT Alinity TBI test within 24 hours of injury
3. Treating emergency department attending physician is not willing to participate
4. Pre-existing neurologic condition
5. Contraindication or inability to complete blood draw
6. Significant polytrauma that, in the opinion of the principal investigators, could impact peripheral GFAP levels or require a full body scan
7. History of penetrating TBI
8. History of neurosurgical intervention for previous TBI
9. Penetrating TBI for current injury
10. Any history of brain surgery
11. Any history of brain tumor
12. Patients on psychiatric hold

Where it's running

  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Shawn Eagle, PhD — University of Pittsburgh
  • Study coordinator: Shawn Eagle, PhD
  • Email: eaglesr2@upmc.edu
  • Phone: 412-624-2041

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.